triazoles has been researched along with Neuroblastoma in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (13.89) | 18.2507 |
| 2000's | 3 (8.33) | 29.6817 |
| 2010's | 18 (50.00) | 24.3611 |
| 2020's | 10 (27.78) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, G; Challagundla, KB; Chaturvedi, NK; Coulter, DW; Griggs, CN; Joshi, SS; Kling, MJ; McIntyre, EM; Ray, S | 1 |
| Lee, DG; Nguyen, R; Peng, J; Sun, M; Thiele, CJ; Wang, H | 1 |
| Abid, S; Hamdi, H; M'nassri, A; Mokni, M; Rich, S; Rjiba-Touati, K | 1 |
| Hwang, JH; Kang, Y; Kim, H; Lee, JU; Mun, SK; Oh, JM; Park, JH; Shin, WH; Yee, ST | 1 |
| Chen, H; Jiang, X; Liu, W; Liu, X; Tian, L; Wang, N; Wu, L; Wu, Q; Wu, Z; Xu, Z; Zhao, C; Zhao, Q | 1 |
| Goyal, B; Goyal, D; Kaur, A; Mann, S; Priyadarshi, N; Singhal, NK | 1 |
| Godugu, K; Karakus, OO; Mousa, SA; Rajabi, M | 1 |
| Adderley, T; Christopher, G; Irwin, MS; Kano, Y; Kee, L; Ladumor, Y; Ohh, M; Robinson, CM; Valencia-Sama, I | 1 |
| Costello, DA; Jones, AC; Pinki, F; Stewart, GS | 1 |
| Basu, M; Lazarski, C; Nelson, M; Sandler, AD; Srinivasan, P; Wu, X; Zhang, P; Zheng, P | 1 |
| Bi, S; Li, Y; Lv, Z; Wang, C; Wang, J; Zhang, J; Zhang, W | 1 |
| Boeva, V; De Preter, K; De Vloed, F; De Wyn, J; Decaesteker, B; Deforce, D; Denecker, G; Depuydt, P; Dolman, EM; Dreidax, D; Durinck, K; Essing, AHW; Gartlgruber, M; Henssen, A; Herrmann, C; Kholosy, WM; Koopmans, B; Loontiens, S; Mestdagh, P; Molenaar, JJ; Nunes, C; Rombaut, D; Schleiermacher, G; Schulte, JH; Speleman, F; Van Loocke, W; van Nes, J; Van Neste, C; Van Nieuwerburgh, F; Vanhauwaert, S; Verboom, K; Versteeg, R; Westermann, F | 1 |
| Alexe, G; Bandopadhayay, P; Beroukhim, R; Cheff, DM; Chen, L; Conway, A; Davis, MI; Goodale, A; Guha, R; Hall, MD; Iniguez, AB; Johannessen, C; Kitara, S; Lee, Y; Menard, M; Nasholm, N; Pantel, S; Patel, S; Piccioni, F; Qi, J; Robichaud, AL; Roti, G; Stegmaier, K; Stolte, B; Wang, EJ; Weiss, WA | 1 |
| Alexe, G; Bassil, CF; Benes, CH; Bradner, JE; Chanthery, YH; Frumm, SM; Garnett, MJ; Greninger, P; Gustafson, WC; Kung, AL; McDermott, U; Nekritz, EA; Puissant, A; Qi, J; Stegmaier, K; Weiss, WA; Zeid, R | 1 |
| Andriolo, V; Castorina, A; Giunta, S | 1 |
| Li, H; Sun, Y; Xu, F | 1 |
| Chung, DH; Craig, BT; Kim, KW; Lee, S; Qiao, J; Rellinger, EJ; Romain, CV | 1 |
| Ahmad, M; Bhat, BA; Dar, NJ; Hamid, A; Lone, AM; Shah, WA | 1 |
| Baryawno, N; Calero, R; Darabi, A; Dyberg, C; Einvik, C; Johnsen, JI; Kogner, P; Kool, M; Milosevic, J; Sandén, E; Siesjö, P; Sveinbjörnsson, B; Wickström, M | 1 |
| Atmadibrata, B; Bradner, JE; Liu, PY; Liu, T; Lock, RB; Marshall, GM; Shahbazi, J | 1 |
| Atmadibrata, B; Liu, PY; Liu, T; Mondal, S; Tee, AE | 1 |
| Atmadibrata, B; Byrne, JA; Cheung, BB; Codd, R; Dinger, ME; Guo, ST; Guo, XY; Haber, M; Itoh, K; Kavallaris, M; Liu, B; Liu, PY; Liu, T; Marshall, GM; Mccarroll, J; Norris, MD; Siddiqi, F; Sokolowski, N; Sun, Y; Tee, AE; Telfer, TJ; Wang, J; Yang, RH; Yu, D; Zhang, L; Zhang, XD; Ziegler, DS | 1 |
| Albasanz, JL; Barrachina, M; Buira, SP; Dentesano, G; Ferrer, I; Martín, M; Moreno, J | 1 |
| Bevilacqua, V; Caldarelli, A; Canonico, P; Genazzani, AA; Giustiniano, M; Massarotti, A; Mesenzani, O; Novellino, E; Pirali, T; Sorba, G; Tron, GC | 1 |
| Cho, EJ; Chueh, HW; Kim, JY; Koo, HH; Lee, SH; Sung, KW; Yoo, KH | 1 |
| Fuskevåg, OM; Gogvadze, V; Johnsen, JI; Kock, A; Kogner, P; Kruspig, B; Rasmuson, A; Simón-Santamaría, J; Sveinbjörnsson, B | 1 |
| Bae, SJ; Chueh, HW; Kang, C; Koo, HH; Lee, SH; Son, MH; Sung, KW; Yoo, KH | 1 |
| Avila, B; Dwyer, DS; Kurth, MJ; Roth, A; Streets, H | 1 |
| Alffenaar, JW; Doedens, RA; Groninger, E; Kosterink, JG | 1 |
| Eckert, A; Mensah-Nyagan, AG; Patte-Mensah, C; Schaeffer, V | 1 |
| Diserbo, M; Fatome, M; Lalouette, F; Martin, C; Verdetti, J | 1 |
| Diserbo, M; Fatôme, M; Verdetti, J | 1 |
| Friedman, E; Horwitz, J; Shi, LC; Wang, HY | 1 |
| Benovic, JL; Kelly, E; Parent, JL; Willets, JM | 1 |
| Sapp, DW; Yeh, HH | 1 |
| Feuerstein, G; Gleason, MM; Hallenbeck, J; Yue, TL | 1 |
1 trial(s) available for triazoles and Neuroblastoma
| Article | Year |
|---|---|
Iron chelation treatment with deferasirox prior to high-dose chemotherapy and autologous stem cell transplantation may reduce the risk of hepatic veno-occlusive disease in children with high-risk solid tumors.
Topics: Acute Kidney Injury; Benzoates; Brain Neoplasms; Child; Child, Preschool; Deferasirox; Erythrocyte Transfusion; Fanconi Syndrome; Female; Ferritins; Hepatic Veno-Occlusive Disease; Humans; Induction Chemotherapy; Infant; Iron Chelating Agents; Male; Neuroblastoma; Stem Cell Transplantation; Transplantation, Autologous; Triazoles | 2012 |
35 other study(ies) available for triazoles and Neuroblastoma
| Article | Year |
|---|---|
Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
Topics: Acetanilides; Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Down-Regulation; Drug Synergism; Eukaryotic Initiation Factor-4E; G1 Phase Cell Cycle Checkpoints; Heterocyclic Compounds, 3-Ring; Humans; N-Myc Proto-Oncogene Protein; Neuroblastoma; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Spheroids, Cellular; TOR Serine-Threonine Kinases; Transcription Factors; Triazoles | 2021 |
Combining selinexor with alisertib to target the p53 pathway in neuroblastoma.
Topics: Animals; Apoptosis; Azepines; Cell Line, Tumor; Humans; Hydrazines; Karyopherins; Mice; Neuroblastoma; Proteomics; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Triazoles; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2022 |
Brain injury, genotoxic damage and oxidative stress induced by Bromuconazole
Topics: Animals; Brain; Brain Injuries; Cell Line; Cell Line, Tumor; DNA Damage; Furans; Glutathione Transferase; Humans; Male; Neuroblastoma; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Triazoles | 2022 |
Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B.
Topics: Acetophenones; Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroblastoma; Structure-Activity Relationship; Triazoles; Tryptamines | 2022 |
Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment.
Topics: Acetylcholinesterase; Alzheimer Disease; Carbolines; Cholinesterase Inhibitors; Glycogen Synthase Kinase 3 beta; Humans; Neuroblastoma; Phosphorylation; tau Proteins; Triazoles | 2022 |
Triazole-Peptide Conjugate as a Modulator of Aβ-Aggregation, Metal-Mediated Aβ-Aggregation, and Cytotoxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Humans; Metals; Molecular Dynamics Simulation; Neuroblastoma; Peptide Fragments; Triazoles | 2023 |
Dual Targeting of Norepinephrine Transporter (NET) Function and Thyrointegrin αvβ3 Receptors in the Treatment of Neuroblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Female; Guanidines; Humans; Integrin alphaVbeta3; Mice, Nude; Necrosis; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Thyroxine; Triazoles; Xenograft Model Antitumor Assays | 2020 |
Topics: Aminopyridines; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Genes, ras; Heterografts; Humans; Indoles; Male; MAP Kinase Signaling System; Mice, Inbred NOD; Mice, SCID; Mitogen-Activated Protein Kinase Kinases; Mutation; Neoplasm Recurrence, Local; Neuroblastoma; Piperidines; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Pyridones; Pyrimidines; Pyrimidinones; Pyrroles; Triazoles; Vemurafenib | 2020 |
Inhibition of Urea Transporter (UT)-B Modulates LPS-Induced Inflammatory Responses in BV2 Microglia and N2a Neuroblastoma Cells.
Topics: Animals; Cell Line, Tumor; Inflammation; Interleukin-6; Lipopolysaccharides; Membrane Transport Proteins; Mice; Microglia; Neuroblastoma; Nitric Oxide; Pyrimidines; Thiophenes; Triazoles; Tumor Necrosis Factor-alpha; Urea Transporters | 2021 |
MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination.
Topics: Aminoquinolines; Animals; Azepines; Benzoates; Cancer Vaccines; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Databases, Genetic; Gene Amplification; Gene Expression Regulation, Neoplastic; Humans; Immune Checkpoint Inhibitors; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neuroblastoma; Proto-Oncogene Proteins c-myc; Signal Transduction; Skin Neoplasms; Triazoles; Tumor Escape; Tumor Microenvironment; Vaccination | 2021 |
LncRNA-MALAT1-mediated Axl promotes cell invasion and migration in human neuroblastoma.
Topics: Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Neuroblastoma; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; RNA, Long Noncoding; Transcriptional Activation; Triazoles | 2017 |
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets.
Topics: Antineoplastic Agents; Azepines; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; DNA Copy Number Variations; Epigenesis, Genetic; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; HEK293 Cells; Histones; Humans; Kv Channel-Interacting Proteins; N-Myc Proto-Oncogene Protein; Neuroblastoma; Organoids; Panobinostat; Phenylenediamines; Pyrimidines; Repressor Proteins; Signal Transduction; T-Box Domain Proteins; Triazoles; Tumor Suppressor Protein p53 | 2018 |
Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling.
Topics: Animals; Azepines; Cell Line, Tumor; Disease-Free Survival; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Humans; Indazoles; Mice, Nude; Molecular Targeted Therapy; Neuroblastoma; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proteins; Signal Transduction; Sulfonamides; Triazoles; Xenograft Model Antitumor Assays | 2018 |
Targeting MYCN in neuroblastoma by BET bromodomain inhibition.
Topics: Animals; Apoptosis; Azepines; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Growth Processes; Cell Line, Tumor; Child; Down-Regulation; Female; Gene Amplification; Humans; Mice; Molecular Targeted Therapy; N-Myc Proto-Oncogene Protein; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Promoter Regions, Genetic; Protein Structure, Tertiary; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; Transcription Factors; Transfection; Triazoles; Xenograft Model Antitumor Assays | 2013 |
Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Aluminum Chloride; Aluminum Compounds; Amyloid beta-Peptides; Apoptosis; Astringents; Blotting, Western; Caffeine; Cell Proliferation; Cells, Cultured; Chlorides; Humans; Lipid Peroxidation; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Purinergic P1 Receptor Antagonists; Pyrimidines; Reactive Oxygen Species; Receptor, Adenosine A1; Receptor, Adenosine A2A; RNA, Small Interfering; Triazoles; Xanthines | 2014 |
Inhibition of Axl improves the targeted therapy against ALK-mutated neuroblastoma.
Topics: Anaplastic Lymphoma Kinase; Animals; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Crizotinib; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Neuroblastoma; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Pyrazoles; Pyridines; Receptor Protein-Tyrosine Kinases; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
Bromodomain and extraterminal inhibition blocks tumor progression and promotes differentiation in neuroblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azepines; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Cell Survival; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; N-Myc Proto-Oncogene Protein; Neuroblastoma; Neurogenesis; Nuclear Proteins; Oncogene Proteins; Random Allocation; Triazoles; Xenograft Model Antitumor Assays | 2015 |
Promise of Retinoic Acid-Triazolyl Derivatives in Promoting Differentiation of Neuroblastoma Cells.
Topics: Animals; Azides; Cell Differentiation; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Mass Spectrometry; Mice; Neuroblastoma; Phosphopyruvate Hydratase; Tretinoin; Triazoles | 2016 |
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
Topics: Animals; Antineoplastic Agents; Benzeneacetamides; beta Catenin; Brain Neoplasms; Camptothecin; Celecoxib; Cisplatin; Colorectal Neoplasms; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Glucose-6-Phosphate Isomerase; Heterocyclic Compounds, 3-Ring; Humans; Immunoblotting; Immunohistochemistry; Irinotecan; Medulloblastoma; Mice; Neoplasm Transplantation; Neoplasms; Neuroblastoma; Pyrans; Pyrazines; Pyridines; Real-Time Polymerase Chain Reaction; Sulfones; Temozolomide; Triazoles; Tumor Suppressor Proteins; Vincristine; Wnt Proteins; Wnt Signaling Pathway | 2015 |
The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azepines; Cell Line, Tumor; Cell Proliferation; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Mice; Mice, Inbred BALB C; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Panobinostat; Promoter Regions, Genetic; Proteins; Proto-Oncogene Proteins c-myc; Transcription, Genetic; Triazoles; Xenograft Model Antitumor Assays | 2016 |
NCYM is upregulated by lncUSMycN and modulates N-Myc expression.
Topics: Azepines; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 4 or More Rings; Histones; Humans; Methylation; Neoplasm Proteins; Neuroblastoma; Nuclear Matrix-Associated Proteins; Octamer Transcription Factors; Prognosis; Promoter Regions, Genetic; Protein Binding; RNA Interference; RNA-Binding Proteins; RNA, Long Noncoding; RNA, Messenger; RNA, Small Interfering; Triazoles | 2016 |
The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Mice; Naphthoquinones; Neuroblastoma; NF-E2-Related Factor 2; Nuclear Proteins; Protein Domains; RNA-Binding Proteins; Small Molecule Libraries; Transcription Factors; Triazoles; Tubulin Modulators; Vincristine; Xenograft Model Antitumor Assays | 2016 |
DNA methylation regulates adenosine A(2A) receptor cell surface expression levels.
Topics: Azacitidine; Cell Line; Chromatin Immunoprecipitation; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; HeLa Cells; Humans; Immunoprecipitation; Methyl-CpG-Binding Protein 2; Neuroblastoma; Protein Binding; Radioligand Assay; Receptor, Adenosine A2A; Receptors, Cell Surface; RNA, Messenger; S-Adenosylmethionine; Time Factors; Triazines; Triazoles; Tritium | 2010 |
Replacement of the double bond of antitubulin chalcones with triazoles and tetrazoles: Synthesis and biological evaluation.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chalcones; Humans; Models, Molecular; Neuroblastoma; Tetrazoles; Triazoles; Tubulin; Tubulin Modulators | 2011 |
Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastoma.
Topics: 16,16-Dimethylprostaglandin E2; Autocrine Communication; Biphenyl Compounds; Blotting, Western; Calcium; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclic AMP; Cyclooxygenase 2 Inhibitors; Dinoprostone; Humans; Immunohistochemistry; In Vitro Techniques; Neuroblastoma; Phosphorylation; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Reverse Transcriptase Polymerase Chain Reaction; Tandem Mass Spectrometry; Thiophenes; Triazoles | 2012 |
Iron overload during follow-up after tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Child; Child, Preschool; Creatinine; Deferasirox; Ferritins; Follow-Up Studies; Humans; Infant; Iron Chelating Agents; Iron Overload; Neuroblastoma; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Transfusion Reaction; Transplantation, Autologous; Triazoles | 2012 |
Triazolbenzo[d]thiazoles: efficient synthesis and biological evaluation as neuroprotective agents.
Topics: Benzothiazoles; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neuroblastoma; Neuroprotective Agents; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2012 |
High-dose voriconazole in a critically ill pediatric patient with neuroblastoma.
Topics: Antifungal Agents; Candidiasis; Child, Preschool; Critical Illness; Humans; Lung Diseases; Male; Neuroblastoma; Pyrimidines; Triazoles; Voriconazole | 2008 |
Selective regulation of neurosteroid biosynthesis in human neuroblastoma cells under hydrogen peroxide-induced oxidative stress condition.
Topics: Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Gene Expression Regulation, Neoplastic; Humans; Hydrogen Peroxide; Letrozole; Neuroblastoma; Nitriles; Oxidative Stress; Serum; Steroids; Tetrazolium Salts; Thiazoles; Time Factors; Triazoles | 2008 |
Presence of specific platelet-activating factor binding-sites in neuroblastoma N1E-115 cells.
Topics: Animals; Azepines; Binding Sites; Binding, Competitive; Brain Neoplasms; Diterpenes; Ginkgolides; Kinetics; Lactones; Mice; Neuroblastoma; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thienopyridines; Triazoles; Tumor Cells, Cultured | 1995 |
Activation of large conductance Ca(2+)-activated K+ channels in N1E-115 neuroblastoma cells by platelet-activating factor.
Topics: Azepines; Calcium; Ion Channel Gating; Membrane Potentials; Neuroblastoma; Neurons; Platelet Activating Factor; Potassium Channels; Triazoles; Tumor Cells, Cultured | 1996 |
Guanine nucleotide regulatory proteins, Gq and Gi1/2, mediate platelet-activating factor-stimulated phosphoinositide metabolism in immortalized hippocampal cells.
Topics: Animals; Azepines; Cell Line, Transformed; Cell Membrane; GTP-Binding Proteins; Guanosine Triphosphate; Hippocampus; Hybrid Cells; Immune Sera; Mice; Mice, Inbred C57BL; Neuroblastoma; Neurons; Pertussis Toxin; Phosphatidylinositols; Platelet Activating Factor; Triazoles; Virulence Factors, Bordetella | 1996 |
Selective reduction in A2 adenosine receptor desensitization following antisense-induced suppression of G protein-coupled receptor kinase 2 expression.
Topics: Animals; beta-Adrenergic Receptor Kinases; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; DNA, Antisense; G-Protein-Coupled Receptor Kinase 2; G-Protein-Coupled Receptor Kinase 3; Gene Expression; Glioma; Homeostasis; Hybrid Cells; Mice; Neuroblastoma; Phosphorylation; Rats; Receptors, Purinergic P1; Transfection; Triazines; Triazoles; Tumor Cells, Cultured | 1999 |
Heterogeneity of GABA(A) receptor-mediated responses in the human IMR-32 neuroblastoma cell line.
Topics: Anticonvulsants; Bicuculline; Diazepam; Dose-Response Relationship, Drug; GABA Modulators; gamma-Aminobutyric Acid; Humans; Neuroblastoma; Patch-Clamp Techniques; Pentobarbital; Pregnanolone; Protein Isoforms; Receptors, GABA-A; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triazoles; Tumor Cells, Cultured; Zinc | 2000 |
Characterization of platelet-activating factor-induced elevation of cytosolic free-calcium level in neurohybrid NCB-20 cells.
Topics: Animals; Azepines; Calcium; Calcium Channel Blockers; Cerebral Cortex; Cricetinae; Cricetulus; Cytosol; Diterpenes; Gallic Acid; Ginkgolides; Hybrid Cells; Lactones; Mice; Neuroblastoma; Platelet Activating Factor; Quinolinium Compounds; Triazoles | 1991 |